12% SECURED CONVERTIBLE NOTEConvertible Security Agreement • July 13th, 2018 • Medite Cancer Diagnostics, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledJuly 13th, 2018 Company Industry JurisdictionTHIS 12% SECURED CONVERTIBLE NOTE is issued by MEDITE CANCER DIAGNOSTICS, INC., a Delaware corporation (the “Company”) (this note, the “Note”).
12% SECURED CONVERTIBLE NOTEConvertible Security Agreement • February 12th, 2018 • Medite Cancer Diagnostics, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledFebruary 12th, 2018 Company Industry JurisdictionTHIS 12% SECURED CONVERTIBLE NOTE is issued by MEDITE CANCER DIAGNOSTICS, INC., a Delaware corporation (the “Company”) (this note, the “Note”).
NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE...Convertible Security Agreement • October 2nd, 2017 • Medite Cancer Diagnostics, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledOctober 2nd, 2017 Company Industry JurisdictionTHIS 13.25% SECURED CONVERTIBLE NOTE is issued at a 2.5% original issue discount by MEDITE CANCER DIAGNOSTICS, INC., a Delaware corporation (the “Company”) (this note, the “Note”).
NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE...Convertible Security Agreement • October 2nd, 2017 • Medite Cancer Diagnostics, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledOctober 2nd, 2017 Company Industry JurisdictionTHIS 13.25% SENIOR SECURED CONVERTIBLE NOTE is issued at an 9.9% original issue discount by MEDITE CANCER DIAGNOSTICS, INC., a Delaware corporation (the “Company”) (this note, the “Note”).